Bindong Liu to Diabetic Nephropathies
This is a "connection" page, showing publications Bindong Liu has written about Diabetic Nephropathies.
Connection Strength
2.748
-
Wang B, Qian JY, Tang TT, Lin LL, Yu N, Guo HL, Ni WJ, Lv LL, Wen Y, Li ZL, Wu M, Cao JY, Liu BC. VDR/Atg3 Axis Regulates Slit Diaphragm to Tight Junction Transition via p62-Mediated Autophagy Pathway in Diabetic Nephropathy. Diabetes. 2021 11; 70(11):2639-2651.
Score: 0.788
-
Zheng M, Lv LL, Cao YH, Liu H, Ni J, Dai HY, Liu D, Lei XD, Liu BC. A pilot trial assessing urinary gene expression profiling with an mRNA array for diabetic nephropathy. PLoS One. 2012; 7(5):e34824.
Score: 0.416
-
Zheng M, Lv LL, Cao YH, Zhang JD, Wu M, Ma KL, Phillips AO, Liu BC. Urinary mRNA markers of epithelial-mesenchymal transition correlate with progression of diabetic nephropathy. Clin Endocrinol (Oxf). 2012 May; 76(5):657-64.
Score: 0.414
-
Zheng M, Lv LL, Ni J, Ni HF, Li Q, Ma KL, Liu BC. Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy. PLoS One. 2011; 6(5):e20431.
Score: 0.389
-
Dai HY, Zheng M, Tang RN, Ni J, Ma KL, Li Q, Liu BC. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy. Am J Med Sci. 2011 Mar; 341(3):207-14.
Score: 0.382
-
Lu J, Chen PP, Zhang JX, Li XQ, Wang GH, Yuan BY, Huang SJ, Liu XQ, Jiang TT, Wang MY, Liu WT, Ruan XZ, Liu BC, Ma KL. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKa activity. Theranostics. 2021; 11(10):4728-4742.
Score: 0.191
-
Lv LL, Feng Y, Wu M, Wang B, Li ZL, Zhong X, Wu WJ, Chen J, Ni HF, Tang TT, Tang RN, Lan HY, Liu BC. Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury. Cell Death Differ. 2020 01; 27(1):210-226.
Score: 0.169